The aim of our study was therefore to analyze CD138 levels in the serum of patients affected by Intact Immunoglobulin Multiple Myeloma or Light Chain Multiple Myeloma and to compare the values obtained with serum FLC kappa (κ) or lambda (λ) chains involved in both groups of myeloma patients. The gene discussed is SDC1; the disease is plasma cell myeloma.